|
additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations are marketed under similar trade names avapro daily dosis reducing Karvea, and Avapro.Contents [hide]1 Clinical use1.1 Indications1.2 Combination with diureticIrbesartan is also available in a combination avapro daily dosis reducing with a low dose thiazide diuretic, invariably.
hydrochlorothiazide, to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations are marketed avapro daily dosis reducing similar trade names to irbesartan preparations, including CoAprovel, Karvezide, Avalide and avapro daily dosis reducing HCT.[edit] avapro daily dosis reducing Lewis EJ, Hunsicker avapro daily dosis reducing Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study Group. (2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.". N Engl J Med 345 (12): 851-60. PMID 11565517.^ Rossi S, editor. Australian Medicines Handbook avapro daily dosis reducing Adelaide: Australian Medicines Handbook 2006. Adelaide: avapro daily dosis reducing Medicines Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from Avapro)Jump to: navigation, searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code.
60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic.
| 
Comments
__________________
http://shop-med.org pharma shop